111 related articles for article (PubMed ID: 8778771)
21. Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons.
Anderson KE; Kliris J; Murphy L; Carmella SG; Han S; Link C; Bliss RL; Puumala S; Murphy SE; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1544-6. PubMed ID: 14693752
[TBL] [Abstract][Full Text] [Related]
22. DNA and hemoglobin adducts as markers of metabolic activation of tobacco-specific carcinogens.
Foiles PG; Murphy SE; Peterson LA; Carmella SG; Hecht SS
Cancer Res; 1992 May; 52(9 Suppl):2698s-2701s. PubMed ID: 1563001
[TBL] [Abstract][Full Text] [Related]
23. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
24. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids.
Hecht SS; Hoffmann D
Eur J Cancer Prev; 1998 Apr; 7(2):165-6. PubMed ID: 9818780
[No Abstract] [Full Text] [Related]
25. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine.
Carmella SG; Akerkar S; Hecht SS
Cancer Res; 1993 Feb; 53(4):721-4. PubMed ID: 8428352
[TBL] [Abstract][Full Text] [Related]
26. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
27. The molecular perspective: polycyclic aromatic hydrocarbons.
Goodsell DS
Stem Cells; 2004; 22(5):873-4. PubMed ID: 15342950
[No Abstract] [Full Text] [Related]
28. Tobacco smoke carcinogens and breast cancer.
Hecht SS
Environ Mol Mutagen; 2002; 39(2-3):119-26. PubMed ID: 11921179
[TBL] [Abstract][Full Text] [Related]
29. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke.
Parsons WD; Carmella SG; Akerkar S; Bonilla LE; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):257-60. PubMed ID: 9521443
[TBL] [Abstract][Full Text] [Related]
30. DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke.
Phillips DH
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):453-8. PubMed ID: 8781363
[TBL] [Abstract][Full Text] [Related]
31. Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.
Khariwala SS; Carmella SG; Stepanov I; Bandyopadhyay D; Nelson HH; Yueh B; Hatsukami DK; Hecht SS
Laryngoscope; 2015 Aug; 125(8):1844-8. PubMed ID: 25877866
[TBL] [Abstract][Full Text] [Related]
32. Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.
Taioli E; Garbers S; Bradlow HL; Carmella SG; Akerkar S; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):517-22. PubMed ID: 9232339
[TBL] [Abstract][Full Text] [Related]
33. Re: metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
Chobanyan NS; Nersesyan AK
J Natl Cancer Inst; 2001 Oct; 93(20):1575-7. PubMed ID: 11604486
[No Abstract] [Full Text] [Related]
34. Carcinogen in tobacco smoke can be passed to fetus.
Wise J
BMJ; 1998 Aug; 317(7158):555. PubMed ID: 9758488
[No Abstract] [Full Text] [Related]
35. Carcinogens and DNA damage.
Barnes JL; Zubair M; John K; Poirier MC; Martin FL
Biochem Soc Trans; 2018 Oct; 46(5):1213-1224. PubMed ID: 30287511
[TBL] [Abstract][Full Text] [Related]
36. Tobacco industry must not dump its high nitrosamine tobacco on poor countries.
Gray N; Boyle P
BMJ; 2001 Mar; 322(7285):557. PubMed ID: 11230082
[No Abstract] [Full Text] [Related]
37. Nicotine: potentially a multifunctional carcinogen?
Campain JA
Toxicol Sci; 2004 May; 79(1):1-3. PubMed ID: 15146885
[No Abstract] [Full Text] [Related]
38. Molecular epidemiology of lung cancer and the modulation of markers of chronic carcinogen exposure by chemopreventive agents.
Perera FP; Tang D; Grinberg-Funes RA; Blackwood MA; Dickey C; Blaner W; Santella RM
J Cell Biochem Suppl; 1993; 17F():119-28. PubMed ID: 8412183
[TBL] [Abstract][Full Text] [Related]
39. Patterns of Carbon-Bound Exogenous Compounds in Patients with Lung Cancer and Association with Disease Pathophysiology.
Kunzke T; Prade VM; Buck A; Sun N; Feuchtinger A; Matzka M; Fernandez IE; Wuyts W; Ackermann M; Jonigk D; Aichler M; Schmid RA; Eickelberg O; Berezowska S; Walch A
Cancer Res; 2021 Dec; 81(23):5862-5875. PubMed ID: 34666994
[TBL] [Abstract][Full Text] [Related]
40. Molecular epidemiology of breast cancer.
Ambrosone CB; Shields PG
Prog Clin Biol Res; 1997; 396():83-99. PubMed ID: 9108591
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
